These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 18362016

  • 1. Association between statin use and mortality in patients with implantable cardioverter-defibrillators and left ventricular systolic dysfunction.
    Coleman CI, Kluger J, Bhavnani S, Clyne C, Yarlagadda R, Guertin D, White CM.
    Heart Rhythm; 2008 Apr; 5(4):507-10. PubMed ID: 18362016
    [Abstract] [Full Text] [Related]

  • 2. Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
    Vyas AK, Guo H, Moss AJ, Olshansky B, McNitt SA, Hall WJ, Zareba W, Steinberg JS, Fischer A, Ruskin J, Andrews ML, MADIT-II Research Group.
    J Am Coll Cardiol; 2006 Feb 21; 47(4):769-73. PubMed ID: 16487843
    [Abstract] [Full Text] [Related]

  • 3. Statin therapy significantly reduces risk of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator.
    Jacob S, Manickam P, Rathod A, Badheka A, Afonso L, Aravindhakshan R.
    Am J Ther; 2012 Jul 21; 19(4):261-8. PubMed ID: 21048429
    [Abstract] [Full Text] [Related]

  • 4. Anti-arrhythmic effects of statins: a hypothesis remains to be tested.
    Guo HM.
    Heart Rhythm; 2008 Apr 21; 5(4):511-2. PubMed ID: 18362017
    [No Abstract] [Full Text] [Related]

  • 5. Reduction in life-threatening ventricular tachyarrhythmias in statin-treated patients with nonischemic cardiomyopathy enrolled in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy).
    Buber J, Goldenberg I, Moss AJ, Wang PJ, McNitt S, Hall WJ, Eldar M, Barsheshet A, Shechter M.
    J Am Coll Cardiol; 2012 Aug 21; 60(8):749-55. PubMed ID: 22703927
    [Abstract] [Full Text] [Related]

  • 6. The effect of statin therapy on ventricular tachyarrhythmias: a meta-analysis.
    Wanahita N, Chen J, Bangalore S, Shah K, Rachko M, Coleman CI, Schweitzer P.
    Am J Ther; 2012 Jan 21; 19(1):16-23. PubMed ID: 20720485
    [Abstract] [Full Text] [Related]

  • 7. Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID Trial.
    Zareba W, Daubert JP, Beck CA, Huang DT, Alexis JD, Brown MW, Pyykkonen K, McNitt S, Oakes D, Feng C, Aktas MK, Ayala-Parades F, Baranchuk A, Dubuc M, Haigney M, Mazur A, McPherson CA, Mitchell LB, Natale A, Piccini JP, Raitt M, Rashtian MY, Schuger C, Winters S, Worley SJ, Ziv O, Moss AJ, RAID Trial Investigators.
    J Am Coll Cardiol; 2018 Aug 07; 72(6):636-645. PubMed ID: 30071993
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention.
    Streitner F, Kuschyk J, Dietrich C, Mahl E, Streitner I, Doesch C, Veltmann C, Schimpf R, Wolpert C, Borggrefe M.
    Clin Cardiol; 2011 Oct 07; 34(10):604-9. PubMed ID: 21887690
    [Abstract] [Full Text] [Related]

  • 17. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy.
    Sesselberg HW, Moss AJ, McNitt S, Zareba W, Daubert JP, Andrews ML, Hall WJ, McClinitic B, Huang DT, MADIT-II Research Group.
    Heart Rhythm; 2007 Nov 07; 4(11):1395-402. PubMed ID: 17954398
    [Abstract] [Full Text] [Related]

  • 18. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA, Banchs JE, Depalma S, Young SK, Penny-Peterson ED, Samii SM, Wolbrette DL, Naccarelli GV, Gonzalez MD.
    J Cardiovasc Electrophysiol; 2012 Mar 07; 23(3):296-301. PubMed ID: 21955243
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.